Form 4 holding
EVP, Technical Operations
SANGAMO THERAPEUTICS, INC
- Security class
- Common Stock
- Shares / value
- 171,467
- Estimated value
- $65,518
- Report date
- 25 May 2023
- Price
- $0.3821
- Ownership
- Direct
Rolf Andrew Ramelmeier
Insider Reports History
- Reporting-owner location
- Brisbane, CA
- Latest reporting-owner signature
-
Rolf Andrew Ramelmeier, by /s/ Ron A. Metzger, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Rolf Andrew Ramelmeier
Insider Reports Filed by Rolf Andrew Ramelmeier
4
SGMO
SANGAMO THERAPEUTICS, INC
- Report period
- 25 May 2023
- Transactions
- 1
- Transaction value
- -$2,328
- Accepted by SEC
- 30 May 2023, 16:44
- Role
- EVP, Technical Operations
- Next action
- Open filing details
4
SGMO
SANGAMO THERAPEUTICS, INC
- Report period
- 24 Feb 2023
- Transactions
- 3
- Transaction value
- -$41,544
- Accepted by SEC
- 06 Mar 2023, 16:09
- Role
- EVP, Technical Operations
- Next action
- Open filing details
4
SGMO
SANGAMO THERAPEUTICS, INC
- Report period
- 25 Feb 2022
- Transactions
- 3
- Transaction value
- -$73,089
- Accepted by SEC
- 01 Mar 2022, 16:19
- Role
- EVP, Technical Operations
- Next action
- Open filing details